AstraZeneca chief investigator backs India’s covishield dose plan
The chief investigator of the AstraZeneca vaccine clinical trials, Professor Andrew Pollard has backed the 12-16 week gap between the…
The chief investigator of the AstraZeneca vaccine clinical trials, Professor Andrew Pollard has backed the 12-16 week gap between the…
Oxford developed vaccine AstraZeneca accidentally reached 90% effectiveness. This happened when some of the trial participants got only half of…
Oxford developed, two dose vaccine AstraZeneca will be made available for purchase and emergency use by early January-February. The AstraZeneca…
“Oxford Vaccine may fit India better than the others being developed such as Moderna and Pfizer”, says Gagandeep Kang, a…